Tolerance of peanuts and tree nuts in Spanish children with exclusive sensitization to lipid transfer proteins.
Pediatr Allergy Immunol
; 35(7): e14204, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-39016336
ABSTRACT
BACKGROUND:
Allergy to peanuts and tree nuts is a common cause of food allergy in Spain, with lipid transfer proteins (LTP) being the most frequently recognized panallergen. LTP sensitization often leads to multiple food group sensitivities, resulting in overly restrictive diets that hinder patient's quality of life. This study aimed to assess the tolerance of peanuts and tree nuts (hazelnuts and walnuts) in children sensitized to LTP, potentially mitigating the need for such diets.METHODS:
This prospective study enrolled individuals diagnosed with allergy to peanuts, hazelnuts, or walnuts. Data were collected from medical records, including demographics and clinical history. Allergological assessment comprised skin prick tests using commercial extracts and the nuts in question, alongside measurements of total and specific IgE to nuts and their primary molecular components. Participants showing positive LTP sensitization without sensitization to seed storage proteins underwent open oral nut challenges.RESULTS:
A total of 75 individuals labeled as allergic to peanuts, 44 to hazelnuts, and 51 to walnuts were included. All of them underwent an open oral provocation test with the incriminated nut, showing a high tolerance rate. Peanut was tolerated by 98.6% of patients, 97.72% tolerated hazelnut, and 84.3% tolerated walnut.CONCLUSION:
The findings suggest that the majority of patients allergic to peanuts, hazelnuts, or walnuts, due to LTP sensitization and lacking IgE reactivity to seed storage proteins, can tolerate these nuts. This supports the need for personalized nut tolerance assessments to avoid unnecessary dietary restrictions.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Arachis
/
Inmunoglobulina E
/
Pruebas Cutáneas
/
Proteínas Portadoras
/
Hipersensibilidad a la Nuez
/
Tolerancia Inmunológica
Límite:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
País como asunto:
Europa
Idioma:
En
Año:
2024
Tipo del documento:
Article